FDA agrees to review Moderna’s mRNA flu vaccine application in a reversal
The FDA is slated to make a decision on the flu shot on Aug. 5, which will allow Moderna to make the vaccine available for the upcoming influenza season.
Palo Alto shares sink 7%, CEO defends cybersecurity’s position as AI hits software stocks
Palo Alto has bet big on AI in recent months and launched an aggressive acquisition spree that included buying CyberArk for $25 billion.
Oil jumps 4% after Vance says Iran ignored key U.S. demands, military strikes on the table
Oil traders are worried that war between the U.S. and Iran could lead to a major disruption of crude supplies in the Middle East.
Mark Zuckerberg said he reached out to Apple CEO Tim Cook to discuss ‘wellbeing of teens and kids’
Meta CEO Mark Zuckerberg took the stand in a closely watched social media and safety trial that could reshape the industry.
The ‘boomcession’: Why Americans feel left behind by a growing economy
A combination of the words “boom” and “recession” can help explain why Americans feel so sour about a growing economy.
Stocks making the biggest moves premarket: Nvidia, New York Times, Palantir & more
These are the stocks posting the largest moves in premarket trading.
Arm shares edge higher as Nvidia sells entire stake in company
SEC filings showed Nvidia has exited its position in the British chip designer, which it once tried to buy for $40 billion.
Britain’s BAE Systems sets sights on defense spending boom amid record order backlog
Shares in the UK defense giant rose on Wednesday after it reported strong full-year earnings.
Watch CNBC’s full interview with Mistral AI CEO Arthur Mensch
Arthur Mensch, CEO of Mistral AI, discusses future growth, competition and AI strategy from the India AI Impact Summit.
CNBC Daily Open: Iran-U.S. talks and Ukraine-Russia negotiations in focus — progress in sight?
Geopolitics will be the main theme of the day, with markets watching the high-stakes talks between the U.S. and Iran, as well as Ukraine and Russia.
